These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27439505)

  • 1. Drug Disposition Classification Systems in Discovery and Development: A Comparative Review of the BDDCS, ECCS and ECCCS Concepts.
    Camenisch GP
    Pharm Res; 2016 Nov; 33(11):2583-93. PubMed ID: 27439505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.
    Benet LZ
    J Pharm Sci; 2013 Jan; 102(1):34-42. PubMed ID: 23147500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs.
    Hosey CM; Chan R; Benet LZ
    AAPS J; 2016 Jan; 18(1):251-60. PubMed ID: 26589308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
    Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
    Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility-Permeability Interplay in Facilitating the Prediction of Drug Disposition Routes, Extent of Absorption, Food Effects, Brain Penetration and Drug Induced Liver Injury Potential.
    Benet LZ
    J Pharm Sci; 2023 Sep; 112(9):2326-2331. PubMed ID: 37429358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).
    Varma MV; Steyn SJ; Allerton C; El-Kattan AF
    Pharm Res; 2015 Dec; 32(12):3785-802. PubMed ID: 26155985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
    Cristofoletti R; Chiann C; Dressman JB; Storpirtis S
    J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Biopharmaceutical Drug Disposition Classification System (BDDCS) by Structural Parameters.
    Golfar Y; Shayanfar A
    J Pharm Pharm Sci; 2019; 22(1):247-269. PubMed ID: 31287788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines.
    Charalabidis A; Sfouni M; Bergström C; Macheras P
    Int J Pharm; 2019 Jul; 566():264-281. PubMed ID: 31108154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system.
    Wu CY; Benet LZ
    Pharm Res; 2005 Jan; 22(1):11-23. PubMed ID: 15771225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the Art and Uses for the Biopharmaceutics Drug Disposition Classification System (BDDCS): New Additions, Revisions, and Citation References.
    Bocci G; Oprea TI; Benet LZ
    AAPS J; 2022 Feb; 24(2):37. PubMed ID: 35199251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDDCS class prediction for new molecular entities.
    Broccatelli F; Cruciani G; Benet LZ; Oprea TI
    Mol Pharm; 2012 Mar; 9(3):570-80. PubMed ID: 22224483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDDCS applied to over 900 drugs.
    Benet LZ; Broccatelli F; Oprea TI
    AAPS J; 2011 Dec; 13(4):519-47. PubMed ID: 21818695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can BDDCS illuminate targets in drug design?
    Bocci G; Benet LZ; Oprea TI
    Drug Discov Today; 2019 Dec; 24(12):2299-2306. PubMed ID: 31585170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting drug disposition via application of a Biopharmaceutics Drug Disposition Classification System.
    Benet LZ
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):162-7. PubMed ID: 20002064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconciling Human-Canine Differences in Oral Bioavailability: Looking beyond the Biopharmaceutics Classification System.
    Martinez MN; El-Kattan A; Awji E; Papich M
    AAPS J; 2019 Aug; 21(5):99. PubMed ID: 31396733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay of biopharmaceutics, biopharmaceutics drug disposition and salivary excretion classification systems.
    Idkaidek NM
    Saudi Pharm J; 2014 Jan; 22(1):79-81. PubMed ID: 24493977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of natural products as sources of drugs according to the biopharmaceutics drug disposition classification system (BDDCS).
    Li J; Larregieu CA; Benet LZ
    Chin J Nat Med; 2016 Dec; 14(12):888-897. PubMed ID: 28262115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
    Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
    Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro disposition profiling of heterocyclic compounds.
    Keemink J; Wuyts B; Nicolaï J; Jonghe SD; Stella A; Herdewijn P; Augustijns P; Annaert P
    Int J Pharm; 2015 Aug; 491(1-2):78-90. PubMed ID: 26043826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.